• Title of article

    CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia

  • Author/Authors

    Oliver E. Bechter، نويسنده , , Wolfgang Eisterer، نويسنده , , Margit Dlaska، نويسنده , , Thomas Kühr، نويسنده , , Josef Thaler، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2002
  • Pages
    8
  • From page
    26
  • To page
    33
  • Abstract
    Objective Expression of the catalytic subunit of the telomerase enzyme hTERT is essential for prolonging the replicative lifespan and is the rate-limiting step in cellular immortalization and carcinogenesis. Because hTERT expression is positively correlated with telomerase activity, its regulation is suggested as the major determinant of enzymatic activity. The hTERT promoter region contains two CpG islands, which are known to be target sites for de novo DNA methylation. To elucidate the impact of this epigenetic mechanism on telomerase activity, we analyzed the degree of hTERT promoter methylation in 30 patients with B-cell chronic lymphocytic leukemia. Materials and Methods hTERT promoter methylation was assessed using a methylation-specific competitive polymerase chain reaction assay. The assay is based on digestion of genomic DNA with a methylation-sensitive restriction enzyme before amplification with an internal standard. Results Patients exhibiting high telomerase activity showed significantly less methylation of the hTERT promoter core domain than patients with low enzyme activity. In addition, telomerase activity was significantly associated with telomere length and overall survival. Conclusions Our data show that the degree of CpG island methylation of the hTERT promoter exhibits an impact on telomerase activity in a subgroup of patients with B-cell chronic lymphocytic leukemia and therefore is assumed to play a role in regulating hTERT gene expression in these patients.
  • Journal title
    Experimental Hematology
  • Serial Year
    2002
  • Journal title
    Experimental Hematology
  • Record number

    513625